Page last updated: 2024-08-17

aldosterone and deferoxamine

aldosterone has been researched along with deferoxamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lucchelli, PE	1
Aizawa, T; Ishizaka, N; Iso-o, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M	1

Trials

1 trial(s) available for aldosterone and deferoxamine

Article	Year
Experimental design in clinical drug research: some practical implications. Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1969, Volume: 2, Issue:1 Topics: Adipose Tissue; Aldosterone; Analysis of Variance; Angiotensin II; Biometry; Clinical Trials as Topic; Deferoxamine; Dietary Proteins; Drug Synergism; Glucose; Humans; Insulin; Methandrostenolone; Methods; Models, Theoretical; Pharmacology; Placebos	1969

Article

Year

Experimental design in clinical drug research: some practical implications.

Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1969, Volume: 2, Issue:1

Topics: Adipose Tissue; Aldosterone; Analysis of Variance; Angiotensin II; Biometry; Clinical Trials as Topic; Deferoxamine; Dietary Proteins; Drug Synergism; Glucose; Humans; Insulin; Methandrostenolone; Methods; Models, Theoretical; Pharmacology; Placebos

1969

Other Studies

1 other study(ies) available for aldosterone and deferoxamine

Article	Year
Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4 Topics: Aldosterone; Angiotensin II; Animals; Chemokine CCL2; Deferoxamine; Enzyme Inhibitors; Ferritins; Fibrosis; Free Radical Scavengers; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Iron; Iron Chelating Agents; Male; Myocardium; Oxidative Stress; Phenylurea Compounds; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents	2005

Article

Year

Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart.

American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4

Topics: Aldosterone; Angiotensin II; Animals; Chemokine CCL2; Deferoxamine; Enzyme Inhibitors; Ferritins; Fibrosis; Free Radical Scavengers; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Iron; Iron Chelating Agents; Male; Myocardium; Oxidative Stress; Phenylurea Compounds; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents

2005